Key facts
- Notable investors include Huayi Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kangruijian
- ·The full record, as it builds
Funding rounds
No funding rounds for Kangruijian are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kangruijian
Manufacturer, provider and developer of chitosan-based hydrogels designed for aesthetic medicine, orthopedics, surgical and cell culture. The company focuses on temperature sensitivity and complete metabolism, enabling clients with chitosan-based hydrogels.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Kangruijian doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kangruijian shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kangruijian in its N-PORT filings yet. We sweep new filings monthly.